Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer

NCT03691012 · clinicaltrials.gov ↗

UNKNOWN

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DIAGNOSTIC_TEST: Circulating tumour DNA testing

Sponsor

Walter and Eliza Hall Institute of Medical Research

Collaborators

[object Object]